THE medtech industry, as represented by the listed stocks on the Singapore Exchange (SGX), has been hurt by market volatility despite the bubbling prospects of the sector.

SHARES of medical technology company Biolidics slumped on their trading debut on the Catalist board, with the stock closing down 16 per cent from its listing price of S$0.28.

SHARES of medical technology company Biolidics opened below their IPO (initial public offering) price on the firm's Catalist debut on Wednesday, with the stock opening at S$0.265, down 5.4 per...

MEDICAL technology company Biolidics on Tuesday launched an initial public offering (IPO) of 27.5 million new shares at S$0.28 each. The placement is in conjunction with its proposed listing on...